![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | C07D 401/06 | |
A61K 31/454 | |||
A61P 5/06 |
(11) | Number of the document | 1768976 |
(13) | Kind of document | T |
(96) | European patent application number | 05766869.1 |
Date of filing the European patent application | 2005-06-22 | |
(97) | Date of publication of the European application | 2007-04-04 |
(45) | Date of publication and mention of the grant of the patent | 2017-04-26 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/US2005/022408 |
Date | 2005-06-22 |
(87) | Number | WO 2006/016995 |
Date | 2006-02-16 |
(30) | Number | Date | Country code |
583757 P | 2004-06-29 | US |
(72) |
LORIMER, Keith, US
PINES, Seemon, H., US
PAUL, Bernhard, US
LITTER, Benjamin, US
|
(73) |
Helsinn Healthcare S.A.,
Via Pian Scairolo, 9, 6912 Lugano / Pazzallo,
CH
|
(54) | CRYSTAL FORMS OF (3R)-1-(2-METHYLALANYL-D-TRYPTOPHYL)-3-(PHENYLMETHYL)-3-PIPERIDINECARBOXYLIC ACID 1,2,2-TRIMETHYLHYDRAZIDE |
CRYSTAL FORMS OF (3R)-1-(2-METHYLALANYL-D-TRYPTOPHYL)-3-(PHENYLMETHYL)-3-PIPERIDINECARBOXYLIC ACID 1,2,2-TRIMETHYLHYDRAZIDE |